RLX Technology, Inc. · NYSE:RLX

RLX Technology — Q4 2022 Earnings Presentation

29 slides from RLX Technology's earnings presentation, Mar 9, 2023

  1. Slide 1: RLX Technology Inc. Earnings Presentation Q4 2022

    RLX Technology Inc. Earnings Presentation Q4 2022 ir.relxtech.com

  2. Slide 2: Disclaimer and forward-looking statements

    The following presentation has been prepared by RLX Technology Inc. (“RLX Technology” or the “Company”) solely for informational purposes and should not be construed to be, directly or indirectly, in whole or in part, an offer to buy or sell and/or an invitation and/or a recommendation and/or a soli

  3. Slide 3: Operational Highlights

    OPERATIONAE HIGHLIGHTS RLX T=CH

  4. Slide 4: Current Product Portfolio

    Current Product Portfolio RLX T=CH QING YU PHANTOM PHANTOM Pro e e ° See a eo Budget Price Point Premium 4

  5. Slide 5: ESG ratings

    A 26.3 45 100 0 0 100 First among our global e-vapor peers A rating of A (on a scale of AAA-CCC) in the MSCI ESG Ratings assessment, a dramatic upward leap from last year's CCC rating. Morningstar Sustainalytics Ratings also lowered our risk level from High Risk to Medium Risk, placing us in the top

  6. Slide 6: Financial Highlights

    FINANCIAL HIGHLIGHTS

  7. Slide 7: Quarterly net revenues, gross margin and non-GAAP net margin

    RMB millions RMB millions Pre-Regulatory Era Pre-Regulatory Era 73.4% 1,904 16,831 16,405 15,734 14,949 50.0% 43.8% 43.6% 40.2% 1,044 38.3% 31.5% 28.2% 28.4% 340 21.1% Gross margin Non-GAAP net margin Q4 2021 Q3 2022 Q4 2022 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2022 • “

  8. Slide 8: Annual net revenues, gross margin and non-GAAP net margin

    RMB millions RMB millions Pre-Regulatory Era Pre-Regulatory Era 8,521 43.1% 43.2% 40.0% 15,734 37.5% 14,858 29.5% 5,333 26.4% 21.0% 3,820 1,549 Gross margin 3,421 6.5% Non-GAAP net margin 812 2019 2020 2021 2022 2019 2020 2021 2022 2019 2020 2021 2022 • “Electronic Cigarette” Mandatory National Stan

  9. Slide 9: Net Revenues by Quarter

    Net Revenues by Quarter RMB millions 2,234 1,904 1,714 1,044 340 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Pre-Regulatory Era Post-Regulatory Era The YoY decrease in quarterly net revenues was primarily due to: • The impact of regulatory changes, which were fully implemented in this quarter, • COVID-1

  10. Slide 10: Net Revenues by Year

    Net Revenues by Year RMB millions 8,521 5,333 3,820 133 1,549 2018 2019 2020 2021 2022 Pre-Regulatory Era Post-Regulatory Era The YoY decrease in yearly net revenues was primarily due to: • The suspension of store expansion • The discontinuation of older products during the transition to the new nat

  11. Slide 11: Gross Margin

    RMB millions Gross Margin 50.0% 43.8% 43.1% 40.2% 40.0% 38.3% 43.6% 43.2% 3,672 2,305 1,528 766 978 657 522 148 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 2020 2021 2022 11

  12. Slide 12: Q4 gross margin drivers

    Favorable Change in Increase in Improvement Product Mix Effective of Supply Ex-factory Chain Price Efficiency Implementation Others of Excise Tax 43.6% 40.2% Q4 2021 Q4 2022 The increase in gross margin was primarily due to supply chain efficiency improvements, an increase in effective ex-factory pr

  13. Slide 13: Full-year gross margin drivers

    Increase in Unfavorable Effective Implementation Improvement Change in Increase in Ex-factory of Excise Tax of Supply Product Mix Inventory Chain Price Provision Efficiency 43.1% 43.2% 2021 2022 The increase in gross margin was primarily due to supply chain efficiency improvements, an increase in ef

  14. Slide 14: Operating Expense Trend

    Operating Expense Trend RMB millions RMB millions RMB millions As % of Net As % of Net As % of Net Revenues Revenues Revenues 9.5% 19.2% 8.3% 16.3% 7.3% 6.4% 6.3% 6.9% 7.3% 6.7% 4.7% 4.5% 4.2% 2.3% 1.2% 164 140 118 122 105 86 93 77 77 70 65 55 45 25 23 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q4 2021

  15. Slide 15: Operating Expense Trend

    Operating Expense Trend RMB millions RMB millions RMB millions As % of Net As % of Net As % of Net Revenues Revenues Revenues 22.8% 7.9% 6.7% 7.8% 6.3% 5.7% 5.7% 4.7% 4.4% 2.0% 2.8% 2.8% 540 415 353 355 371 301 306 239 178 88 106 31 2019 2020 2021 2022 2019 2020 2021 2022 2019 2020 2021 2022 Note: e

  16. Slide 16: Non-GAAP reconciliation

    For the Three Months Ended For the Year Ended (In RMB thousands) Dec 31, 2021 Sep 30, 2022 Dec 31, 2022 Dec 31, 2021 Dec 31, 2022 Net Income 494,415 505,240 (225,125) 2,028,124 1,408,732 Add: Share-based Compensation Expenses Selling Expenses 1,885 (24,189) 41,239 (19,653) (6,993) General and Admini

  17. Slide 17: Capital Resources

    Capital Resources RMB millions Long-term Investment Securities Long-term Bank Deposits Short-term Investments Short-term Bank Deposits Restricted Cash Cash And Cash Equivalents 17

  18. Slide 18: Income statement

    For the Three Months Ended For the Year Ended (In RMB thousands) Dec 31, 2021 Sep 30, 2022 Dec 31, 2022 Dec 31, 2021 Dec 31, 2022 Net Revenues 1,904,355 1,044,424 340,012 8,520,978 5,332,779 Cost of Revenues (1,138,826) (522,451) (139,073) (4,848,918) (2,974,981) Exercise Taxes on Products - - (52,6

  19. Slide 19: Balance sheet: assets

    As of (In RMB thousands) Dec 31, 2021 Dec 31, 2022 ASSETS Current Assets Cash and Cash Equivalents 5,208,967 1,268,512 Restricted Cash 500 20,574 Short-Term Bank Deposits, net 4,022,119 7,084,879 Receivables From Online Payment Platforms 10,006 3,000 Short-Term Investments 3,621,637 2,434,864 Accoun

  20. Slide 20: Balance sheet: liabilities and shareholders' equity

    As of (In RMB thousands) Dec 31, 2021 Dec 31, 2022 LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities Accounts And Notes Payable 1,288,845 269,346 Contract Liabilities 286,651 75,226 Salary And Welfare Benefits Payable 170,393 127,749 Taxes Payable 597,761 109,676 Amounts Due To Related Partie

  21. Slide 21: Cash flow statement

    For the Three Months Ended For the Year Ended (In RMB thousands) Dec 31, 2021 Sep 30, 2022 Dec 31, 2022 Dec 31, 2021 Dec 31, 2022 Net Cash Generated From / (Used In) Operating Activities 465,738 (1,016,862) (248,866) 1,799,892 486,829 Net Cash (Used In) / Generated From Investing Activities (1,397,5

  22. Slide 22: Appendix

    APPENDIX RLX T=CH

  23. Slide 23: Nicotine Delivery Systems

    Heat Closed-Pod System Not E-Cigarette RELX Branded Other Burn Nicotine Products Disposable Novel Delivery E-Cigarette Tobacco Systems Refillable Products Modern Open-System Oral E-Cigarette From E-liquid to Aerosol Using an atomizer to heat up e-liquid in a cartridge to produce aerosol without fire

  24. Slide 24: Global e-cigarette regulation: Europe, Asia, Americas

    Europe • United Kingdom: Prescribe medicinally licensed e-cigarettes to help reduce smoking rates. E-cigarettes are currently taxed as a consumer product, with the VAT rate being 20%. Restrict e-liquids to a nicotine strength of no more than 20mg/ml and require nicotine-containing products or their

  25. Slide 25: China e-cigarette regulatory timeline

    Pre-Regulatory Era On Oct 30, 2019, the State Administration On Nov 26, 2021, China’s State Council announced it had On Mar 18, 2022, On Oct 1, 2022, the E-Cigarettes for Market Regulation (SAMR) and the State amended the Regulations for the Implementation of the RELX was selected as Administrative

  26. Slide 26: Company milestones

     Initiated the Introduced Guardian Program RELX Alpha to promote the JAN prevention of APR underage use FEB  We commenced of our products AUG • Launched RELX i, our first smart e-vapor product operations on Jan • Exclusive production plant began operations 2, 2018, and 2019 2023 launched RELX  La

  27. Slide 27: Scientific research and R&D process

    本品含有尼古丁,尼古丁是一种令人上瘾的化学物质,未成年人、非吸烟者不应使用本产品。 By June 2022: In 2021: The Whole R&D Process User Evaluation Formula Adjustments Product Tests Patents Filed Globally Cooperative Research Projects Stable product quality is the cornerstone of scientific research. The only way to draw meaningful scientific con

  28. Slide 28: Management team

    本品含有尼古丁,尼古丁是一种令人上瘾的化学物质,未成年人、非吸烟者不应使用本产品。 Ms. Ying (Kate) Wang Mr. Long (David) Jiang Mr. Yilong Wen Mr. Chao Lu Co-founder Co-founder Co-founder Chief Executive Officer Head of China Sales Head of supply chain, product development Chief Financial Officer and scientific research • Ms. Wang served in

  29. Slide 29: RLX Technology Inc.

    RLX Technology Inc. Earnings Presentation Q4 2022 ir.relxtech.com

RLX Technology — Q4 2022 Earnings Presentation on 6ix